Furthermore, after the clinical development of IL-2, IL-2 was also found to play a pivotal role in the expansion and maintenance of Treg cells by inhibiting CD8 + T-cell activation in the tumor microenvironment (TME)68. This evidence concerns the gene IL2 and neoplasm.